Pfizer to ship smaller packages of COVID-19 vaccine to cut waste, boost uptake
Sep 03, 2021
CDC says smaller packages of the vaccine may be available by October
Israeli study shows Pfizer booster gives seniors big rise in immunity
Aug 23, 2021
Israel approved booster shots for people aged 60 years and older late last month; the government lowered the age of eligibility to 40 years last week
Moderna vaccine may shield more against breakthrough infections than Pfizer: study
Aug 12, 2021
Findings based on non-peer-reviewed, preprint data
Pfizer finds itself playing defense after shelving a promising Alzheimer’s treatment
By
Alicia Lasek
Jun 06, 2019
A large pharmaceutical company has come under fire, following reports that it failed to pursue a promising Alzheimer’s disease treatment.
Also in the News for Wednesday, Jan. 10
Jan 10, 2018
Pfizer ends its quest to develop Alzheimer’s and Parkinson’s drugs … Nearly 70 Wisconsin seniors fear eviction amid Medicaid dispute … Hawaiian program gives family caregivers who...
Also in the news for August 15, 2014 . . .
Aug 15, 2014
High-dose flu vaccine about 25% more effective for seniors … Regular internet use reduces dementia risk in seniors, scientists say … Expert panel recommends seniors receive Pfizer pneumonia...
Pharma companies embrace branding
By
Elizabeth Newman
Mar 01, 2014
Big pharmaceutical companies are exploring “brand personality” in their marketing strategies, according to new research.
Pfizer study reveals pneumonia drug effective for the elderly
Feb 25, 2014
Pfizer Inc. said it is planning on presenting the results of its Community-Acquired Pneumonia Immunization Trial in Adults study next month, and that it may have significant impact on preventing community-acquired...
CompanyBriefs
May 01, 2013
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury’s previous...
Experimental drug prevents blood clots from forming in legs and lungs
Dec 11, 2012
The experimental drug Eliquis prevented blood clots in the legs and lungs and kept them from recurring, according to a new study. Patients who took the medicine were 81% less likely to have symptoms of...